Popular vitamin B3 supplements could weaken cancer therapy effectiveness
View as a Web Page
News Medical
 
  Oncology Oncology logo  
  The latest oncology news from News Medical  
 Metformin mimics exercise-related metabolic effects in prostate cancer patientsMetformin mimics exercise-related metabolic effects in prostate cancer patients
 
A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects in men with prostate cancer, raising levels of a molecule tied to energy balance and weight control even when patients are inactive.
 
 
 Popular vitamin B3 supplements could weaken cancer therapy effectivenessPopular vitamin B3 supplements could weaken cancer therapy effectiveness
 
Millions of Americans take daily supplements-nicotinamide mononucleotide (NMN), nicotinamide riboside (NR) and nicotinamide (NAM)-to boost energy, slow aging and protect the heart and brain.
 
   "Smart" system distinguishes and neutralizes cancer cells with unprecedented precision"Smart" system distinguishes and neutralizes cancer cells with unprecedented precision
 
A team from UNIGE has designed a molecular system that distinguishes and neutralizes cancer cells with unprecedented precision, paving the way for autonomous, self-regulating drugs.
 
   Gene-edited treatment shows promising outcomes for severe sickle cell diseaseGene-edited treatment shows promising outcomes for severe sickle cell disease
 
New results from a clinical trial show promising outcomes for a gene-edited treatment for severe sickle cell disease, a genetic blood disorder with few curative options.
 
   Aging reshapes breast tissue creating environment favorable for cancerAging reshapes breast tissue creating environment favorable for cancer
 
Scientists have created the most detailed map to date, comprised of over 3 million cells, showing how breast tissue changes as women age – including dramatic changes during menopause.
 
 New directions in cell therapy: iPSC platforms and in vivo reprogramming
 
New directions in cell therapy: iPSC platforms and in vivo reprogrammingAdvances in iPSC technology and in vivo reprogramming are expanding the possibilities for cell therapy. Explore the science behind these emerging strategies.
 
 
 Princeton researchers reveal new links between high-fat diets and aggressive breast cancer
 
Princeton researchers reveal new links between high-fat diets and aggressive breast cancerPrinceton researchers have revealed new links between high-fat diets and aggressive breast cancer, demonstrating the important role fat plays in making some cancers more invasive.
 
 
 Mayo Clinic researchers develop experimental nanotherapy to treat aggressive brain tumors
 
Mayo Clinic researchers develop experimental nanotherapy to treat aggressive brain tumorsMayo Clinic researchers developed an experimental nanotherapy that delivers two cancer drugs directly to brain tumors, according to a study published in Communications Medicine.
 
 
 NCCN conference highlights advances in global cancer care strategies
 
NCCN conference highlights advances in global cancer care strategiesThe National Comprehensive Cancer Network® (NCCN®)-a non-profit alliance of leading cancer centers-brought together more than a thousand oncology professionals at the NCCN 2026 Annual Conference in Orlando, Florida, with hundreds more joining virtually.
 
 
 Blood-based test could personalize treatment for patients with HPV-associated throat cancer
 
Blood-based test could personalize treatment for patients with HPV-associated throat cancerResearchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) are advancing the understanding of a promising blood test that could personalize treatment and surveillance for patients with human papillomavirus (HPV)-associated throat cancer.
 
 
 Study reveals how bacterial collagenase efficiently breaks down collagen
 
Study reveals how bacterial collagenase efficiently breaks down collagenCollagen is an important protein that helps build the tissues of humans and animals. It is very strong because it is made of three protein strands twisted tightly together like a rope. Because of this sturdy structure, ordinary protein-cutting enzymes usually cannot break it down.
 
 
 High-dose radiation improves survival in large bile duct tumors
 
High-dose radiation improves survival in large bile duct tumorsA new study from researchers at The University of Texas MD Anderson Cancer Center demonstrates that a specialized high-dose type of radiation delivery may significantly improve outcomes for patients with large bile duct tumors in the liver, known as intrahepatic cholangiocarcinoma.
 
 
 JMIR Publications' new article showcases the transformative potential of precision oncology
 
JMIR Publications' new article showcases the transformative potential of precision oncologyJMIR Publications today announced the release of a timely new article in its News and Perspectives section, showcasing the transformative potential of precision oncology.
 
 
 NCCN grants funding to five oncology leaders of the future
 
NCCN grants funding to five oncology leaders of the futureThe National Comprehensive Cancer Network® (NCCN®)-an alliance of leading cancer centers-announces the 2026 recipients for the annual NCCN Foundation® Young Investigator Awards.
 
 
 Tumor microenvironment drives resistance to ferroptosis in pancreatic cancer
 
Tumor microenvironment drives resistance to ferroptosis in pancreatic cancerTumors driven by cancer-driving KRAS mutations are often susceptible to ferroptosis, a type of cell death that can be harnessed for cancer therapy.
 
 
 International researchers set new standards for studying tumor microbiota
 
International researchers set new standards for studying tumor microbiotaRecent research shows that tumors in different organs host microbial communities capable of influencing cancer biology, immune responses, and the effectiveness of therapies, highlighting the need to standardize methods for studying intratumoral microbes.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026